Wafik S. El-Deiry: Very informative and interesting discussions at WIN Consortium in Molecular Tumor Board

Wafik S. El-Deiry shared on LinkedIn:

“Very informative and interesting discussions of three challenging clinical cases from North America, Europe, and Asia at today’s international WIN Consortium in cancer personalized medicine Molecular Tumor Board.”

Source: Wafik S. El-Deiry/LinkedIn

More posts by Wafik S. El-Deiry in OncoDaily.

Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.

He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.